The founder of medical device company MediSieve, George Frodsham, will be presenting at the TCT Show, which is taking place at the NEC Birmingham from 26-28 September.
Tracey Croggon bigTimages
George Frodsham
www.bigTimages.co.uk
The show will let manufacturers, designers, business leaders, early adopters and investors see a range of manufacturing technology that is driving the industry.
Frodsham will be talking about the benefits and advantages that 3D printing can provide to the medtech and medical device industries.
On September 27, the TCT Magazine 2017 Awards ceremony will take place. MediSieve have been nominated for an award in the Healthcare Application category for their potentially life-saving magnetic blood filtration device. The device filters infected cells from a patient's bloodstream and could help improve treatment of malaria.
MediSieve is now beginning research into ways to broaden the applications of their device and is looking into potential treatments for sepsis and leukaemia.
About his talk, Frodsham commented on the value of 3D printing to the company’s device, saying it was “an invaluable tool for us, particularly in the early days of development of our magnetic blood filtration technology.
“Most important was the role it played in the iterative development of early prototypes. We frequently needed to change small physical aspects of our design, going back and forth from the lab to the workshop in order to get something that worked to our satisfaction. Our rep rap 3D printer enabled us to do this easily, quickly and cheaply.
“The ability to get prototypes rapidly made to high quality and the ability to easily make small changes continues to benefit our R&D today as we diversify our technology to be able to treat a number of different diseases.” He continued.
You can listen to the talk by George Frodsham at the TCT show on 27 September 2017 at 13.30.